Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Rooibos-plant-SA-rooibos-councilResearchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form of diabetes, known as “type 3” diabetes and Alzheimer’s disease.

As with all types of dementia, Alzheimer’s is caused by a combination of genetic, lifestyle and environmental factors that affect the health of the brain over a period of time, but now scientists have discovered a strong connection between the disease and insulin resistance in the brain – also referred to as type 3 diabetes.

Prof Christo Muller, chief specialist scientist at the SA Medical Research Council (SAMRC) describes Alzheimer’s as a neurodegenerative disease in the aged, which involves the progressive loss of nerve cells and connections.

‘Type 1 and 2 diabetes are typically characterised by hyperglycaemia (high blood sugar) whereas type 3 diabetes is a more complex disease that has its origin in the central nervous system.

‘Many type 2 diabetics have deposits of a protein called beta-amyloid in their pancreas, which is similar to the protein deposits found in the brain tissue of Alzheimer’s sufferers. According to research published in the World Journal of Diabetes, this increases type 2 diabetics’ risk of Alzheimer’s disease by between 50 percent and 65 percent,’ remarks Muller.

Current research suggests that rooibos has the potential to delay or prevent the onset and progression of type 2 diabetes, however its effect on the associated risk of type 3 diabetes and Alzheimer’s disease still needs to be elucidated.

Muller says phenolic compounds present in rooibos enhances the body’s antioxidant defences helping to fight a variety of oxidative stress-induced conditions. ‘The brain is one of the organs most sensitive to oxidative stress, and long-term exposure to increased levels of free radicals causes damage to neural cells. Dietary antioxidants, such as those found in rooibos, could thus protect vulnerable neurons against the impact of oxidative by-products.

‘Rooibos tea is a rich source of dietary antioxidants, including flavonoids, such as dihydrochalcone glucoside, aspalathin and nothofagin. Aspalathin, in particular, helps to modify hormones in the body and reduces the output of adrenal hormones specifically, thus reducing stress and helping to inhibit metabolic disorders.

‘Aspalathin also helps to regulate blood sugar and therefore can play a role in reducing the risk of type 2 diabetes and excessive fat production. Our research at the SAMRC found that an aspalathin-enriched extract of green rooibos was particularly effective at lowering raised blood glucose levels in diabetic rats. Aspalathin is a unique phenolic compound (a chemical produced by the plant to help protect itself from negative environmental factors), limited to the genus Aspalathus, which has demonstrated a significant contribution to the biological benefits of rooibos,’ he says.

Studies conducted on the anti-diabetic properties of Rooibos by the SAMRC and the Agricultural Research Council (ARC), including those done in overseas laboratories, span more than 10 years’ of intensive work. In a more recent study conducted by Prof Muller and his team of researchers from SAMRC, rooibos extract achieved significant glucose- and cholesterol-lowering results in diabetic primates, which has been described as a breakthrough discovery. Human trials have been earmarked for 2018.

Rooibos, in conjunction with a healthy lifestyle is certain to benefit everyone,’ concludes Prof Muller.

Currently, an estimated one in 14 South Africans between the ages of 21 and 79 suffer from diabetes. Alzheimer’s is reported to affect 750 000 South Africans.



Latest


26 Apr 2021
BASF incubator sees its first startup success with BOXLAB Services

BOXLAB Services is the first startup to celebrate its spin-off from Chemovator in April 2021, and will now operate as…

BASF incubator sees its first startup success with BOXLAB Services

BOXLAB Services is the first startup to celebrate its spin-off from Chemovator in April 2021, and will now operate as an independent entity on the open market. There, promising ideas outside of the core business of BASF are developed and build into scalable business models and companies. With the right…

20 Apr 2021
Care for sensitive skin in winter with Metaupon surfactants

Your wardrobe isn’t the only thing you should be changing as winter approaches – you also need to relook your…

Care for sensitive skin in winter with Metaupon surfactants

Your wardrobe isn’t the only thing you should be changing as winter approaches – you also need to relook your skin care regimen. Those lightweight gel moisturisers and charcoal cleansers that worked just fine in the summer months simply won’t cut it in winter. As colder temperatures approach, dry air,…

20 Apr 2021
SAHPRA finds no causal relationship between Johnson and Johnson vaccine and blood clot development

Findings from SAHPRA’S Sisonke Phase 3b study suggests there are no major safety concerns related to the Johnson and Johnson…

SAHPRA finds no causal relationship between Johnson and Johnson vaccine and blood clot development

Findings from SAHPRA’S Sisonke Phase 3b study suggests there are no major safety concerns related to the Johnson and Johnson COVID-19 vaccine. SAHPRA, together with its scientific expert committees, has reviewed the data from the Sisonke Phase 3b implementation study which involves the administration of the COVID-19 vaccine Janssen, which…

20 Apr 2021
Short film shines a spotlight on the cruelty of animal testing

Have you watched the evocative short film about animal testing called Save Ralph yet? Hollywood filmmakers and movie stars joined…

Short film shines a spotlight on the cruelty of animal testing

Have you watched the evocative short film about animal testing called Save Ralph yet? Hollywood filmmakers and movie stars joined forces with Humane Society International to produce the powerful stop-motion animated short film to end cosmetic testing on animals around the world, including South Africa. Although banned in 40 countries,…


Top stories


25 Jun 2020
How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a…

How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a changing environment, whether it be internal or external. Qualities of agile businesses include being adaptive, flexible and creative in your response to change without losing momentum (remaining productive) or vision.…

01 May 2020
Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex,…

Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex, which continuously invests in technological advancements to meet requirements in diverse industries – has increased production capacity of materials so desperately needed during the global COVID-19 pandemic,” explains Rosa Naidoo,…

23 Apr 2020
Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love.…

Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love. Santam, Fairlady and, for the first time this year, Truelove Magazine, have partnered up in the search to find the best female entrepreneurs in the country. Best women entrepreneurs If…

11 Aug 2020
CBD down-scheduled to an SO product in SA

According to SAHPRA, in Government Notice No. 586, Government Gazette No. 43347, issued on 22 May 2020, the Minister of…

CBD down-scheduled to an SO product in SA

According to SAHPRA, in Government Notice No. 586, Government Gazette No. 43347, issued on 22 May 2020, the Minister of Health has amended the scheduling of CBD. Previous entries for cannabis, dronabinol, and tetrahydrocannabinol in Schedule 7 have been deleted. Cannabidiol (CBD) is listed in Schedule 4, except in: complementary…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za